Esperion Therapeutics reported $303.98M in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amarin AMRN:US $ 973.24M 0.47M
Amgen AMGN:US $ 59294M 98M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Cytokinetics CYTK:US $ 771.72M 84.54M
Daiichi Sankyo 4568:JP Y 2294549M 73147M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Intra Cellular Therapies ITCI:US $ 811.91M 56.67M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
Minerva Neurosciences NERV:US $ 64.96M 5.66M
Moderna Inc MRNA:US 26.04B 1.57B
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Puma Biotechnology PBYI:US $ 193.65M 7.03M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
United Therapeutics UTHR:US $ 5543.3M 183.5M
Vanda Pharmaceuticals VNDA:US $ 609.1M 5.54M